Huepenbecker, Sarah P.
Fu, Shuangshuang
Sun, Charlotte C.
Zhao, Hui
Primm, Kristin M.
Giordano, Sharon H.
Meyer, Larissa A.
Article History
First Online: 26 October 2022
DISCLOSURE
: L.A.M. reports consulting fees from Bristol Meyers Squibb, advisory board participation for GlaxoSmithKline, and stocks in Crisper, Invitae, and Bristol-Myers Squibb. C.C.S. reports partial research funding from AstraZeneca and stock in Inform Genomics. The remaining authors report no conflicts of interest.